-+ 0.00%
-+ 0.00%
-+ 0.00%
3 ASX Stocks Trading Below Cash Flow Value Investors May Want To Watch
Share
Listen to the news

With inflation, energy prices and interest rate expectations pulling at markets from all sides, cash flow has become one of the clearest anchors for stock selection. The Undervalued Stocks Based On Cash Flows screener focuses on companies where projected cash generation and SWS DCF fair value sit above what the market is currently pricing in. That gap signals potential opportunity for value oriented investors who care about what a business can actually produce in cash terms. In this article, you will see 3 stocks from this screener that stand out on cash flow and valuation grounds.

Mesoblast (ASX:MSB)

Overview: Mesoblast (ASX:MSB) is a Melbourne based biotech company developing regenerative cell therapies using mesenchymal lineage cells to treat severe inflammatory and cardiovascular conditions, including graft versus host disease, inflammatory bowel disease, chronic low back pain and heart failure. Its pipeline is supported by multiple late stage trials and partnerships with established pharmaceutical groups across key therapeutic areas.

Operations: Mesoblast currently generates about US$65.4 million in revenue from developing its cell technology platform for commercialization.

Market Cap: A$3.0b

Mesoblast provides exposure to late stage cell therapies where cash flow potential is closely tied to a growing base of approved and near term products, including Ryoncil in pediatric steroid refractory acute GvHD with broad U.S. reimbursement. Analysts expect very strong revenue and earnings growth, with forecasts pointing to profit margins moving from deep losses to solid profitability and earnings of over US$200 million by 2029, although their views vary widely. At the same time, Mesoblast is still loss making, relies on external funding and faces meaningful trial, regulatory and reimbursement risk as it pushes into larger chronic indications like chronic low back pain and heart failure. That combination of high growth expectations, funding needs and clinical milestones makes the valuation highly sensitive to new data and positions the company as one to watch closely.

Mesoblast’s story is shifting from early stage promise to potentially scaling cash flows, and the market may not be pricing that fully. Get the context behind the growth forecasts and funding risks in the analyst forecasts for Mesoblast

ASX:MSB Earnings & Revenue Growth as at Jul 2026
ASX:MSB Earnings & Revenue Growth as at Jul 2026

Lynas Rare Earths (ASX:LYC)

Overview: Lynas Rare Earths (ASX:LYC) is a Perth based producer that mines and processes rare earth minerals from its Mt Weld operation in Western Australia and refines them into materials used in electric vehicles, wind turbines and electronics through plants in Kalgoorlie and Malaysia.

Operations: Lynas Rare Earths generates about A$715.9 million in revenue from its Rare Earth Operations segment.

Market Cap: A$15.2b

Lynas Rare Earths sits at the heart of the push for non Chinese supply of key magnet materials, with earnings that grew 62% over the past year and forecasts for rapid revenue and profit expansion supported by government backed demand and new downstream projects like the Malaysian magnet factory partnership running through 2038. At the same time, the stock is trading below the Simply Wall St estimated cash flow fair value, while analysts expect strong earnings growth and solid future returns on equity. However, high financial leverage, regulatory scrutiny in Malaysia and rich current P/S multiples mean any setback in policy support, electrification demand or project execution could affect both cash flows and valuation more significantly than optimistic scenarios assume.

Lynas Rare Earths is at the center of the electric vehicle and wind turbine build out, yet the market price and cash flow story seem out of sync. See how that gap looks in the DCF valuation analysis for Lynas Rare Earths

LYC Discounted Cash Flow as at Jul 2026
LYC Discounted Cash Flow as at Jul 2026

WiseTech Global (ASX:WTC)

Overview: WiseTech Global (ASX:WTC) develops and sells cloud based software that helps freight forwarders, customs brokers and other logistics providers manage the movement and storage of goods and data across global supply chains. Its CargoWise platform and related tools are used across the Americas, Asia Pacific, Europe, the Middle East and Africa to handle everything from bookings and customs filings to warehousing and documentation.

Operations: WiseTech Global generates its revenue from logistics software solutions sold across the Americas, Asia Pacific and Europe, Middle East and Africa, with the Americas contributing about US$450.7 million, Asia Pacific US$254.8 million and Europe, Middle East and Africa US$364.2 million.

Market Cap: A$10.5b

WiseTech Global is attracting interest because its CargoWise platform sits at the core of supply chain digitization, with unified, AI driven SaaS products, acquisitions like E2open and new tools such as Container Transport Optimization aimed at expanding its reach and recurring cash flows. At the same time, you are dealing with real tension points, including slowing organic growth, profit margins that moved from 27.3% to 15.2%, integration risk on a large E2open deal and higher leverage from a A$3.0b debt facility. The stock currently trades below Simply Wall St’s DCF estimate. Analysts see room for earnings growth and recent governance changes, including an independent chair, suggest a reset that could matter more than the headline P/E ratio implies.

WiseTech Global’s growth story and valuation are pulling in different directions, and the missing piece is how its cash flows stack up against that price. Get the full picture inside the DCF valuation analysis for WiseTech Global

WTC Discounted Cash Flow as at Jul 2026
WTC Discounted Cash Flow as at Jul 2026

The three stocks covered here are only a sample of what screens well on cash flow and valuation, with the full Undervalued Stocks Based On Cash Flows tool turning up 35 more companies that share similarly compelling cash generation stories and pricing gaps. Identify the setups that fit your own playbook by using Simply Wall St to filter the Undervalued Stocks Based On Cash Flows screener for specific catalysts and narratives such as funding runway, balance sheet strength and projected DCF upside so you can focus on the highest conviction ideas.

Take Control of Your Investment Journey

If WiseTech Global or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond These Picks?

Markets move fast and the best breakout stories rarely stay under the radar for long. Scan fresh momentum and cash flow setups before the crowd catches on and consider reviewing potential opportunities in advance.

  • Spot under the radar quality by scanning a curated set of 12 high quality undiscovered gems that pair healthy balance sheets with compelling business models while they are still flying below most radars.
  • Review a focused group of 29 best rare earth metal stocks in the critical materials space that could be relevant if supply conditions change and attention shifts to secure sourcing.
  • Zero in on consistency by filtering a hand picked 8 resilient stocks with low risk scores that aims to surface companies with steadier risk profiles while others focus on fast dropping, more volatile trades.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending